Trials / Terminated
TerminatedNCT02606994
Effect of Over-the-counter Toothpastes on Chemotherapy-induced Oral Mucositis
Comparison of the Healing of Chemotherapy-Induced Oral Mucositis Using Oral Defense Toothpaste Versus Crest Toothpaste and Magic Mouth Rinse
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 1 (actual)
- Sponsor
- Oral Defense, LLC · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether Oral Defense Toothpaste causes accelerated healing of chemotherapy-induced oral mucositis.
Detailed description
A pilot study showed that patients with chemotherapy-induced oral mucositis experienced accelerated healing of their oral mucositis by brushing with Oral Defense Toothpaste. In this study, participants experiencing up to grade 2 chemotherapy-induced oral mucositis will be split into two arms. The first arm (test arm) will receive Oral Defense Toothpaste and be required to brush three times per day, for 8 days. The second arm (control arm) will receive Crest Toothpaste and be required to brush three times per day, for 8 days. Patients in the control arm will be provided Magic Mouth Rinse, if needed. Healing of oral mucositis lesions will be evaluated at days 1 and 8. Quality of life assessment (determination of pain/loss of oral function) will be determined using a daily questionnaire.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Oral Defense Toothpaste | Brush with a Oral Defense Toothpaste three times per day during the study |
| DRUG | Crest Toothpaste | Brush with Crest Toothpaste three times per day during the study |
| DRUG | Magic Mouth Rinse | Participants using Crest Toothpaste who require additional pain intervention for their oral mucositis will be provided Magic Mouth Rinse |
Timeline
- Start date
- 2018-05-29
- Primary completion
- 2019-02-04
- Completion
- 2019-02-04
- First posted
- 2015-11-17
- Last updated
- 2019-02-06
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02606994. Inclusion in this directory is not an endorsement.